Graphical Abstract Highlight Research 1. Synbiotic diets increased intestinal mucin-2 expression without affecting systemic pro-inflammatory genes (IL-1β and TNF-α). 2. Prebiotic, probiotic, and synbiotic treatment significantly increased non-specific immune responses, such as respiratory burst, phagocytic activity, and plasma protein levels. 3. Prebiotic-fed fish exhibited the greatest weight gain and protein efficiency, indicating better nutrient utilization. 4. A synbiotic cocktail (Bacillus tropicus PCP1, Lactococcus garvieae JAL37, and inulin) reduced mortality after Streptococcus agalactiae challenge, indicating its potential application for early disease prevention. Abstract Streptococcal disease remains a persistent constraint in red hybrid tilapia culture, prompting interest in dietary strategies supporting growth and host defense. However, responses to individual and combined supplements across nutritional, systemic immune, mucosal, and infection-related endpoints remain insufficiently characterized within a common experimental framework. This study compared dietary inulin, a probiotic combination of Bacillus tropicus PCP1 and Lactococcus garvieae JAL37, and their synbiotic combination in red hybrid tilapia (Oreochromis sp.). Fish received control, prebiotic, probiotic, or synbiotic diets for 60 days in a completely randomized design with three replicate tanks per treatment. Survival following Streptococcus agalactiae challenge was monitored for seven days. The bacterial challenge began on day 30; immune responses were assessed on days 30 and 60. The prebiotic group exhibited the highest weight gain (48.62 ± 1.2 g), compared with 30.28 ± 0.9 g in controls. Respiratory burst activity and total plasma protein differed among treatments at both sampling times, whereas phagocytic activity differed on day 30 but not day 60. Superoxide dismutase activity showed no significant treatment differences. Synbiotic-fed fish exhibited the highest intestinal Muc-2 expression, while splenic TNF-α and IL-1β expression remained comparable across treatments. Although the synbiotic group displayed higher survival during the early challenge period, survival converged toward day 7, reaching 0% in controls, 7% in the probiotic group, and 3% in both prebiotic and synbiotic groups. Thus, supplementation produced formulation-specific responses in growth, innate immune activity, and intestinal Muc-2 expression, but early survival differences did not translate into sustained protection against bacterial infection.
Copyrights © 2026